I believe a deal was in talks with the RC 110 formula then with the progress of RC220 the deal would've been put on hold until the pharmaceutical company knows that the new formula will work within patients with no crystallisation within the blood etc. I believe that the deal could be struck at any stage. I'm guessing it's the Japanese pharmaceutical company but I could be wrong.
RAC Price at posting:
$1.18 Sentiment: Buy Disclosure: Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)